Keyphrases
Magnetic Resonance Imaging
100%
Renal Mass
100%
Urinary Tract
100%
Mass Appraisal
100%
Ultrasound Computed Tomography
100%
Whole-body
50%
Minimally Invasive
50%
Prostate
50%
Computed Tomography
50%
Response to Therapy
50%
Positron Emission Tomography-computed Tomography (PET-CT)
50%
Prostate-specific Antigen
50%
Radiation Exposure
50%
Clinical Scenarios
50%
CT-MRI
50%
Non-invasive Diagnostics
50%
Extent of Disease
50%
Doppler Ultrasound
50%
Urologists
50%
Image Quality
50%
PET-MRI
50%
Technical Parameters
50%
Adrenal Mass
50%
Response to Treatment
50%
Acquisition Time
50%
Urology
50%
Interventional Radiologist
50%
Image-guided
50%
Urologic Diseases
50%
Stone Disease
50%
Multiparametric MRI (mpMRI)
50%
Contrast-enhanced Ultrasound
50%
Treatment Complications
50%
Diagnostic Imaging Tools
50%
Dual-energy CT
50%
Accurate Identification
50%
Increased Demand
50%
Novel Radiotracers
50%
Diffusion Time
50%
Procedural Planning
50%
Gray-scale Ultrasound
50%
High-quality Imaging
50%
Urinary Tract Anomalies
50%
Technologic
50%
Prostate Cancer Recurrence
50%
Urological Malignancies
50%
MR Technology
50%
Axumin
50%
Grayscale Imaging
50%
Dose Reduction Techniques
50%
Medicine and Dentistry
Magnetic Resonance Imaging
100%
Urinary Tract
100%
Ultrasound Computed Tomography
100%
Diseases
75%
Diagnostic Imaging
50%
Uropathy
50%
Positron Emission Tomography-Computed Tomography
25%
Cancer
25%
Prostate Cancer
25%
Computer Assisted Tomography
25%
Radioactive Tracer
25%
Kidney Tumour
25%
Radiation Exposure
25%
Urologist
25%
Urology
25%
Image Quality
25%
Cancer Recurrence
25%
Positron Emission Tomography - Magnetic Resonance Imaging
25%
Interventional Radiologist
25%
Dual Energy Computed Tomography
25%
Drug Dose Reduction
25%
Doppler Flowmetry
25%
Contrast-Enhanced Ultrasound
25%
Fluciclovine F 18
25%
Prostate Specific Membrane Antigen
25%
Doppler Ultrasound
25%